Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK

Research output: Contribution to journalArticlepeer-review


  • H M Earl
  • L Hiller
  • J Dunn
  • I Macpherson
  • L Hughes-Davies
  • K McAdam
  • P Hall
  • J Mansi
  • D Wheatley
  • J E Abraham
  • C Caldas
  • S Gasson
  • E O'Riordan
  • M Wilcox
  • D Miles
  • D A Cameron
  • A Wardley

Colleges, School and Institutes

External organisations

  • Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
  • University of Warwick Library, University of Warwick
  • (20) Institute of Cardiovascular and Medical Sciences, University of Glasgow, University Avenue, Glasgow, G12 8QQ, UK
  • Cancer Research UK Clinical Trials Unit (CRCTU), School of Cancer Sciences, University of Birmingham, Birmingham, UK.
  • Institute of Cancer and Genomic Sciences
  • Cambridge University Hospitals NHS Foundation Trust
  • Edinburgh Cancer Research Centre, University of Edinburgh
  • Guy's and St Thomas' NHS Foundation Trust and King's College Medical School
  • Royal Cornwall Hospitals NHS Trust
  • Independent Cancer Patients Voice
  • Mount Vernon Cancer Centre, Mount Vernon Hospital, Northwood, UK.
  • Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.


Original languageEnglish
JournalClinical Oncology
Publication statusE-pub ahead of print - 25 Jul 2020